SCHEMBL29889142

SCHEMBL29889142

CC1CN(c2cc(Br)ccn2)C[C@H](C)O1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ LRRK2 Q5S007 8/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ TDP1 Q9NUW8 2/20 0.45
▸ PIK3CD O00329 2/20 0.44
▸ PIK3CA P42336 2/20 0.44
▸ PIK3CB P42338 2/20 0.44
▸ KDM4E B2RXH2 3/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ GAA P10253 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ ACACB O00763 1/20 0.43
▸ HPGD P15428 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42
▸ PIK3CG P48736 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ POLB P06746 1/20 0.39
▸ WNT1 P04628 1/20 0.39
▸ GSK3B P49841 1/20 0.39
▸ DYRK1A Q13627 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22290812 1.00 LRRK2 (0.46) LRRK2KMT2ATDP1PIK3CDPIK3CA
SCHEMBL22290811 1.00 LRRK2 (0.46) LRRK2KMT2ATDP1PIK3CDPIK3CA
SCHEMBL30729441 1.00 LRRK2 (0.46) LRRK2KMT2ATDP1PIK3CDPIK3CA
SCHEMBL4550904 0.81 TDP1 (0.58) LRRK2KMT2ATDP1PIK3CDPIK3CA
SCHEMBL2725997 0.81 TDP1 (0.58) LRRK2KMT2ATDP1PIK3CDPIK3CA
SCHEMBL23860614 0.81 NMT1 (0.46) LRRK2KMT2AHTTACACB
SCHEMBL31400968 0.81 KDM4E (0.50) LRRK2KMT2ATDP1PIK3CDPIK3CA
SCHEMBL2726000 0.81 TDP1 (0.58) LRRK2KMT2ATDP1PIK3CDPIK3CA
SCHEMBL28402936 0.81 LRRK2 (0.47) LRRK2KMT2ATDP1PIK3CDPIK3CA
SCHEMBL21812486 0.78 ACACB (0.45) LRRK2KMT2APIK3CAKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4323351-A1 COMPOSITIONS AND METHODS FOR TREATING CANCER A2A Pharmaceuticals, Inc. (US) 2024-02-21 — — EP disclosed
WO-2022221194-A1 COMPOSITIONS AND METHODS FOR TREATING CANCER A2A PHARMACEUTICALS, INC. (US) 2022-10-20 — — WO disclosed
Send feedback